Comparison of ranibizumab versus dexamethasone for macular oedema following retinal vein occlusion: 1-year results of the COMRADE extension study
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of ranibizumab versus dexamethasone for macular oedema following retinal vein occlusion: 1-year results of the COMRADE extension study
Authors
Keywords
-
Journal
ACTA OPHTHALMOLOGICA
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-06-01
DOI
10.1111/aos.13770
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The efficacy and safety of intravitreal dexamethasone implants for macular oedema secondary to retinal vein occlusion: 3-year experience
- (2016) Aisling Higham et al. ACTA OPHTHALMOLOGICA
- Clinical Efficacy and Safety of Ranibizumab Versus Dexamethasone for Central Retinal Vein Occlusion (COMRADE C): A European Label Study
- (2016) Hans Hoerauf et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Retinal Vein Occlusions Preferred Practice Pattern® Guidelines
- (2016) Jose S. Pulido et al. OPHTHALMOLOGY
- Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study)
- (2016) Samantha Fraser-Bell et al. OPHTHALMOLOGY
- The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary
- (2015) S Sivaprasad et al. EYE
- Prospective Evaluation of Morphological and Functional Changes after Repeated Intravitreal Dexamethasone Implant (Ozurdex®) for Retinal Vein Occlusion
- (2015) Francesco Bandello et al. OPHTHALMIC RESEARCH
- Optimal Treatment of Retinal Vein Occlusion: Canadian Expert Consensus
- (2015) Alan R. Berger et al. OPHTHALMOLOGICA
- OBSERVED COMPLICATIONS FROM DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA IN RETINAL VEIN OCCLUSION OVER 3 TREATMENT ROUNDS
- (2015) Gerard A. Reid et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Monthly OCT monitoring of Ozurdex for macular oedema related to retinal vascular diseases: re-treatment strategy (OCTOME Report 1)
- (2014) R Mathew et al. EYE
- A Randomized Clinical Trial of Intravitreal Bevacizumab versus Intravitreal Dexamethasone for Diabetic Macular Edema
- (2014) Mark C. Gillies et al. OPHTHALMOLOGY
- Risk Factors for Central and Branch Retinal Vein Occlusion: A Meta-Analysis of Published Clinical Data
- (2014) Petr Kolar Journal of Ophthalmology
- Efficacy and Safety of Intravitreal Therapy in Macular Edema Due to Branch and Central Retinal Vein Occlusion: a Systematic Review
- (2013) Amelie Pielen et al. PLoS One
- Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-Month Outcomes of a Phase III Study
- (2011) David M. Brown et al. OPHTHALMOLOGY
- Dexamethasone Intravitreal Implant in Patients with Macular Edema Related to Branch or Central Retinal Vein Occlusion
- (2011) Julia A. Haller et al. OPHTHALMOLOGY
- Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study
- (2011) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein Occlusion
- (2010) Julia A. Haller et al. OPHTHALMOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started